MARS1

Methionine--tRNA ligase, cytoplasmic · P56192 · MARS1 on Sugi Atlas →

7,112 patent compounds predicted against MARS1, 3,910 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL117650 SCHEMBL117650 1.00 19/20
SCHEMBL116345 SCHEMBL116345 1.00 18/20
SCHEMBL116346 SCHEMBL116346 1.00 18/20
SCHEMBL116364 SCHEMBL116364 1.00 18/20
SCHEMBL117374 SCHEMBL117374 1.00 18/20
SCHEMBL117471 SCHEMBL117471 1.00 18/20
SCHEMBL117498 SCHEMBL117498 1.00 18/20
SCHEMBL117499 SCHEMBL117499 1.00 18/20
SCHEMBL117647 SCHEMBL117647 1.00 18/20
SCHEMBL117705 SCHEMBL117705 1.00 18/20
SCHEMBL116352 SCHEMBL116352 1.00 17/20
SCHEMBL117716 SCHEMBL117716 1.00 17/20
SCHEMBL118666 SCHEMBL118666 1.00 17/20
SCHEMBL117667 SCHEMBL117667 0.60 16/20
SCHEMBL117660 SCHEMBL117660 1.00 14/20
SCHEMBL118672 SCHEMBL118672 1.00 14/20
SCHEMBL116301 SCHEMBL116301 1.00 13/20
SCHEMBL116342 SCHEMBL116342 1.00 13/20
SCHEMBL117500 SCHEMBL117500 1.00 13/20
SCHEMBL1110928 SCHEMBL1110928 0.53 13/20

Clinical trials — most relevant to MARS1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. PHASE1/PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor PHASE1/PHASE2NOT_YET_RECRUITING
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment PHASE2COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence nanNOT_YET_RECRUITING
Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione nanCOMPLETED
Dietary Effects of Sulfur Amino Acids nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical Study nanNOT_YET_RECRUITING
A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer nanUNKNOWN
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients nanCOMPLETED
SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Screening of Lysosomal Storage Disorders Diseases in Minority Groups nanUNKNOWN
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Plant-based Diets and Body Weight and Selected Metabolic Parameters Management in Obese Patients. nanCOMPLETED
UW Undiagnosed Genetic Diseases Program nanRECRUITING
Role and Interactions of Adenosine, Receptors, Methionine Cycle Nutritional, Metabolic and Genetic Determinants in the Onset of Atrial Fibrillation in Normal Heart nanUNKNOWN
Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a MARS1 binder may also engage these)

ProteinNameSimilarity
Q2T9L8 1.000 Q2T9L8 →
Q68FL6 1.000 Q68FL6 →
Q6PF21 1.000 Q6PF21 →
Q04462 0.999 Q04462 →
Q15031 0.995 Q15031 →
Q8BYM8 0.987 Q8BYM8 →
P49696 0.985 P49696 →
MARS2 Methionine--tRNA ligase, mitochondrial 0.985 landscape →
Q5RDP4 0.985 Q5RDP4 →
Q60967 0.983 Q60967 →
Q4R646 0.983 Q4R646 →
Q922E4 0.983 Q922E4 →
Q9Y7Y8 0.983 Q9Y7Y8 →
Q9ZTS1 0.983 Q9ZTS1 →
Q9Z1Q9 0.983 Q9Z1Q9 →
VARS1 Valine--tRNA ligase 0.982 landscape →
Q4R550 0.982 Q4R550 →
Q5ZKA2 0.982 Q5ZKA2 →
COASY Bifunctional coenzyme A synthase 0.982 landscape →
Q7ZU90 0.981 Q7ZU90 →
P28350 0.981 P28350 →
Q9SVN5 0.981 Q9SVN5 →
Q5RCH4 0.981 Q5RCH4 →
Q7QIL2 0.981 Q7QIL2 →
A1VKF9 0.981 A1VKF9 →
Q08BC6 0.981 Q08BC6 →
Q91V92 0.981 Q91V92 →
Q9JX22 0.981 Q9JX22 →
B3M1E1 0.981 B3M1E1 →
Q8VDC0 0.981 Q8VDC0 →